Meticulous observation and aggressive treatment, together with long-term hospital stay and a multidisciplinary approach resulted in a successful pregnancy and delivery in a woman with pulmonary arterial hypertension (PAH), as reported by a case study published in the journal Tanaffos.
Articles by Özge Özkaya, PhD
A triple combination therapy with Tracleer (bosentan), Viagra (sildenafil), and Veletri (epoprostenol) can completely reverse right ventricular remodeling that occurs in pulmonary hypertension, according to a case study published in the medical journal Respiratory Medicine Case Reports.
Iron deficiency or low iron levels do not seem to be associated with pulmonary hypertension (PH), a study published in the scientific journal Plos One suggests.
Pharmacologically inhibiting an enzyme called tryptophan hydroxylase 1 (TPH1) that plays a role in serotonin biosynthesis can significantly reduce pulmonary arterial pressure, as well as pulmonary blood vessel wall thickness and blockade, according to a study published in the Journal of Pharmacology and Experimental Therapeutics.
Nitric oxide inhalation can significantly improve oxygen supply in newborn babies with pulmonary hypertension according to a study published in the journal European Review for Medical and Pharmacological Sciences.
Chinese scientists have identified a large number of proteins that are differentially expressed in the blood of people with pulmonary arterial hypertension associated with congenital heart disease (CHD-PAH), for the first time.
A team of researchers at Columbia University Medical Center and New York Presbyterian Hospital advise patients with pulmonary hypertension no to become pregnant, based on the case of a 28-year-old woman who was diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), or group 4 pulmonary hypertension, during her pregnancy.
Early pulmonary hypertension and long term infections in babies that are born prematurely increase their likelihood of developing severe bronchopulmonary dysplasia (BPD), also known as chronic lung disease of infancy, according to a study published in the scientific journal Global Pediatric Health.
The French biotechnology company Mifcare recently announced, in a press release, that their lead anti-inflammatory compound, MFC1040 has been shown to be efficient in a second animal model of pulmonary arterial hypertension (PAH).
A new study published in the scientific journal Respiration suggests that bronchoscopy with transbronchial and endobronchial biopsy and transbronchial needle aspiration are safe in patients with echocardiographic evidence of PH.
Drugs that suppress the immune system should be used together with drugs that dilate the arteries, to treat pulmonary arterial hypertension (PAH) associated with adult-onset Still’s disease (AOSD) according to a new study published in the journal Respiratory Medicine Case Reports.
Pulmonary hypertension can be detected using echocardiography earlier than previously thought according to a new study conducted on newborn mice.